Prostate cancer 'crisis' due to a shortage of specialist nurses, charity warns 

Prostate Cancer UK says that two-fifths of urology cancer nurse specialists are approaching retirement or plan to leave the job in the next decade.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

This study aims to investigate the antiproliferative activity and potential mechanism of action of the xanthoquinodin JBIR-99, isolated from fungi Parengyodontium album MEXU 30,054 and identified by single-crystal X-ray crystallography. Cytotoxicity of xanthoquinodin was evaluated in a panel of human cancer cells lines and CCD-112-CoN normal colon cells, using the sulforhodamine B assay. PC-3 prostate cancer cells were used in biochemical assays including cell cycle, mitochondrial transmembrane potential (MTP), reactive oxygen species (ROS) and caspase activity. Expression levels of apoptosis-pathway-related proteins were ...
Source: Chemico-Biological Interactions - Category: Molecular Biology Authors: Tags: Chem Biol Interact Source Type: research
A $35 million gift from Inc. co-founder and co-CEO Marc Benioff and his wife Lynne targets research in prostate cancer, which killed Marc Benioff's father in 2012. The gift is the latest in a succession of philanthropy from the Benioffs to UCSF, most notably the largest gift behind construction of UCSF Benioff Children's Hospital in Mission Bay and the ongoing work at UCSF Benioff Children's Hospital Oakland. Most recently, the couple gave $35 million last m onth to UCSF and Stanford…
Source: Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
The study was published Sept. 18 in the journal Cell Communication and Signaling.
Source: SUNY Upstate Medical - Category: Universities & Medical Training Source Type: news
Condition:   Prostatic Neoplasms Interventions:   Procedure: Radical Prostatectomy;   Other: Radical Radiotherapy Sponsors:   Tongji Hospital;   Changhai Hospital;   Zhejiang University;   Sun Yat-sen University;   Cancer Institute and Hospital, Chinese Academy of Medical Sciences;   Tianjin Medical University Second Hospital Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Localized prostate cancer (PCa) has a high cure rate of 95.5%. PCa patients receive radiation therapy (RT) as a standard of care treatment. However, the major concern is the treatment-related side effects compromising the quality of life (QoL) in PCa patients. Radiation-induced Erectile Dysfunction (RiED) is a common and irreversible late side effect of RT, that develops in more than half of PCa patients. There is no FDA approved drug to treat RiED. Phosphodiesterase type 5 inhibitors (PDE5i) are the most common pharmacological agents being used to treat RiED.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Source Type: research
Mounting evidence supports complete metastatic ablation for oligometastatic cancer but the relevance of this approach to oligometastatic prostate cancer (OMPC) remain an area of active study. Importantly, biomarkers to determine patients who benefit most from complete ablation are unknown. We hypothesize that stereotactic ablative radiation (SABR) will improve oncologic outcomes in men with OMPC.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Source Type: research
Salvage radiation therapy (SRT) is recommended for men with biochemically recurrent prostate cancer post-radical prostatectomy. RTOG 9601 was a randomized phase 3 clinical trial that demonstrated an overall survival (OS) benefit from the addition of long-term anti-androgen therapy to SRT. However, hormone therapy has well documented side effects and has been shown to increase cardiac event rates, and there remains no evidence of an OS benefit from hormone therapy for men treated with early SRT. Herein, we aim to determine if pre-SRT PSA can serve as both a prognostic and predictive biomarker of benefit or harm from hormone therapy.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Source Type: research
Healthcare systems are often compared with the aviation industry. Progress in both is highly desired but must always be achieved with safety in mind. Everyone wants to get from point A to point B faster and more comfortably, but how much risk of uncertainty is one ready to accept to achieve that extra speed? Both industries also share the aspect of competition for customers. In the field of localized prostate cancer, patients have an ever-increasing choice of options: radical surgery (open vs laparoscopic vs robot-assisted), external beam radiation therapy (EBRT) (with photons or protons), brachytherapy (low-dose rate or h...
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Clinical Investigation Source Type: research
PROSTATE cancer symptoms may not appear for many years because this type of cancer develops slowly. While some of the first symptoms are directly linked to the prostate, signs the cancer has advanced may appear in other parts of the body, including the eyes.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Publication date: Available online 17 September 2019Source: Microbial PathogenesisAuthor(s): Azar Najafi, Mohammad Reza Chaechi Nosrati, Ezatollah Ghasemi, Zahra Navi, Ali Yousefi, Hamidreza Majidiani, Hori Ghaneialvar, Kourosh Sayehmiri, Ma De la Luz Galvan-Ramirez, Mahdi FakharAbstractWe performed a systematic review and meta-analysis to reveal the association between Trichomonas vaginalis (TV) infection and the risk of prostate cancer (PCa) development. Systematic searching (PubMed/Medline, Scopus, Embase, Web of Science, Cinhal, Wiley, Cochrane, Psychoinfo, ProQuest and Google Scholar) was done, up to March 2018 for ca...
Source: Microbial Pathogenesis - Category: Infectious Diseases Source Type: research
More News: Cancer | Cancer & Oncology | Health | Nurses | Nursing | Prostate Cancer | Urology & Nephrology